Peer Support In Dialysis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

57 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-06

Study Completion Date

2023-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Peer mentoring is an approach used to support patients through their experience. In the End Stage Kidney Disease community many patients find out about their kidney failure without warning. This study is designed to test the feasibility of a structured peer support program, specifically, patient uptake, engagement and patient and staff perspectives.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Peer Mentorship to Improve Outcomes in Patients on Maintenance Hemodialysis

NCT03595748

Dialysis

COMPLETED NA

Learning From Our Patients, Learning From Our Practice: Implementing an Intervention to Support Patients on Dialysis

NCT04924582

Dialysis

COMPLETED NA

Pilot Study of an Educational Program for Adults on Hemodialysis With Fatigue

NCT03825770

Renal Dialysis Fatigue Rehabilitation +2 more

COMPLETED NA

Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease

NCT03090828

End-stage Renal Disease Dialysis Kidney Transplantation

UNKNOWN NA

Dialysis CHW Pilot

NCT05998850

Chronic Kidney Diseases RENAL INSUFFICIENCY, CHRONIC

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Renal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

We aim to conduct the study over 6 to 12 months to obtain enough experience to enable feasibility evaluation.

Mentor pool sample size: We anticipate having about 10 patients in the mentors' pool during the study period.

Mentee sample size: We anticipate approaching between 20 to 30 dialysis patients over the study period.

Supporting team: All members of the supporting staff will be invited to participate.

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mentee

Participants will be approached by a mentor, exchange experiences and invite the prospective mentee to the program. Those interested to continue will undergo matching based on their desired criteria.

Group Type EXPERIMENTAL

Mentoring

Intervention Type BEHAVIORAL

At least one meeting between the mentor and mentee will occur to share experiences and see if the mentee would like to continue meeting with a mentor

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mentoring

At least one meeting between the mentor and mentee will occur to share experiences and see if the mentee would like to continue meeting with a mentor

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients living with dialysis or kidney transplant, who volunteer to support other patients.
* Mentor participants agree to complete the CMS End Stage Renal Disease Network Peer Mentoring training program (https://www.kidneylearninghub.com/patients-peer-mentoring-program/ ) and follow the guidelines for participation in the program.

* All incident (new) dialysis patients or their care partners, within the first three months of dialysis.

OR

* Prevalent dialysis patients or their care partners identified by the clinical team to need peer support.

* referring physicians, the medical director of the center, social workers, nurses, patient care technicians (PCT), certified clinical hemodialysis technicians (CCHT), and administrative staff.
* Support staff are those who interact with mentors or mentees as part of their routine work.
* Formally participate in supporting the program by identifying candidates, introducing them to the program, or providing them with support.

Exclusion Criteria

* Age \<18 years.
* Patient cannot communicate in English.
* Concerns raised by the clinical team that may expose the mentor, mentee, staff, or the program to risks, as identified by the clinical team and discussed with the principal investigator.

* Age \< 18 years.
* Significant physical or psychological health conditions (including cognitive impairment) that would limit the patient's ability to interact with the mentor, AND care partner not available or reachable to join the program.
* This criteria will be subjectively evaluated by the clinical team.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No